nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—brain cancer—malignant glioma	0.902	1	CtDrD
Hydroxyurea—Radiation injury—Temozolomide—malignant glioma	0.00868	0.117	CcSEcCtD
Hydroxyurea—Metastatic neoplasm—Temozolomide—malignant glioma	0.00475	0.0643	CcSEcCtD
Hydroxyurea—Fibrosis—Carmustine—malignant glioma	0.0033	0.0446	CcSEcCtD
Hydroxyurea—Skin necrosis—Carmustine—malignant glioma	0.0027	0.0365	CcSEcCtD
Hydroxyurea—Pulmonary fibrosis—Carmustine—malignant glioma	0.00214	0.029	CcSEcCtD
Hydroxyurea—Pulmonary fibrosis—Temozolomide—malignant glioma	0.00207	0.028	CcSEcCtD
Hydroxyurea—Lung infiltration—Carmustine—malignant glioma	0.00201	0.0272	CcSEcCtD
Hydroxyurea—Myelosuppression—Carmustine—malignant glioma	0.00201	0.0272	CcSEcCtD
Hydroxyurea—Myelosuppression—Temozolomide—malignant glioma	0.00194	0.0263	CcSEcCtD
Hydroxyurea—Skin hyperpigmentation—Carmustine—malignant glioma	0.00158	0.0214	CcSEcCtD
Hydroxyurea—Febrile neutropenia—Carmustine—malignant glioma	0.00157	0.0212	CcSEcCtD
Hydroxyurea—Febrile neutropenia—Temozolomide—malignant glioma	0.00151	0.0205	CcSEcCtD
Hydroxyurea—Digestion impaired—Temozolomide—malignant glioma	0.00136	0.0184	CcSEcCtD
Hydroxyurea—Hepatotoxicity—Carmustine—malignant glioma	0.00122	0.0165	CcSEcCtD
Hydroxyurea—Hepatotoxicity—Temozolomide—malignant glioma	0.00118	0.016	CcSEcCtD
Hydroxyurea—Amenorrhoea—Temozolomide—malignant glioma	0.00104	0.014	CcSEcCtD
Hydroxyurea—RRM2—embryo—malignant glioma	0.000994	0.153	CbGeAlD
Hydroxyurea—Hepatic enzyme increased—Temozolomide—malignant glioma	0.000963	0.013	CcSEcCtD
Hydroxyurea—Skin exfoliation—Carmustine—malignant glioma	0.0009	0.0122	CcSEcCtD
Hydroxyurea—Skin exfoliation—Temozolomide—malignant glioma	0.000869	0.0118	CcSEcCtD
Hydroxyurea—Neoplasm—Carmustine—malignant glioma	0.000852	0.0115	CcSEcCtD
Hydroxyurea—Neoplasm—Temozolomide—malignant glioma	0.000823	0.0111	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—STMN1—malignant glioma	0.000797	0.0441	CbGpPWpGaD
Hydroxyurea—Hepatic failure—Temozolomide—malignant glioma	0.000735	0.00995	CcSEcCtD
Hydroxyurea—RRM1—retina—malignant glioma	0.00073	0.112	CbGeAlD
Hydroxyurea—RRM1—telencephalon—malignant glioma	0.000671	0.103	CbGeAlD
Hydroxyurea—Face oedema—Carmustine—malignant glioma	0.00066	0.00893	CcSEcCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—STMN1—malignant glioma	0.000656	0.0364	CbGpPWpGaD
Hydroxyurea—Face oedema—Temozolomide—malignant glioma	0.000638	0.00863	CcSEcCtD
Hydroxyurea—Breast disorder—Temozolomide—malignant glioma	0.000597	0.00808	CcSEcCtD
Hydroxyurea—CYP2D6—CYP2E1 reactions—CYP2B6—malignant glioma	0.000583	0.0323	CbGpPWpGaD
Hydroxyurea—Pancytopenia—Carmustine—malignant glioma	0.000561	0.0076	CcSEcCtD
Hydroxyurea—Neutropenia—Carmustine—malignant glioma	0.000553	0.00748	CcSEcCtD
Hydroxyurea—Pancytopenia—Temozolomide—malignant glioma	0.000543	0.00734	CcSEcCtD
Hydroxyurea—Dysuria—Temozolomide—malignant glioma	0.000534	0.00723	CcSEcCtD
Hydroxyurea—Neutropenia—Temozolomide—malignant glioma	0.000534	0.00723	CcSEcCtD
Hydroxyurea—RRM1—medulla oblongata—malignant glioma	0.000527	0.0812	CbGeAlD
Hydroxyurea—Weight increased—Temozolomide—malignant glioma	0.00052	0.00703	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Carmustine—malignant glioma	0.000517	0.00699	CcSEcCtD
Hydroxyurea—Stomatitis—Carmustine—malignant glioma	0.000514	0.00695	CcSEcCtD
Hydroxyurea—Infestation—Temozolomide—malignant glioma	0.000509	0.00689	CcSEcCtD
Hydroxyurea—Infestation NOS—Temozolomide—malignant glioma	0.000509	0.00689	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Temozolomide—malignant glioma	0.000499	0.00676	CcSEcCtD
Hydroxyurea—Stomatitis—Temozolomide—malignant glioma	0.000496	0.00672	CcSEcCtD
Hydroxyurea—RRM1—midbrain—malignant glioma	0.000482	0.0742	CbGeAlD
Hydroxyurea—Hepatobiliary disease—Temozolomide—malignant glioma	0.000482	0.00652	CcSEcCtD
Hydroxyurea—Haemoglobin—Carmustine—malignant glioma	0.000476	0.00643	CcSEcCtD
Hydroxyurea—Haemorrhage—Carmustine—malignant glioma	0.000473	0.0064	CcSEcCtD
Hydroxyurea—Hallucination—Carmustine—malignant glioma	0.000471	0.00637	CcSEcCtD
Hydroxyurea—RRM1—spinal cord—malignant glioma	0.00047	0.0724	CbGeAlD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—TOP2A—malignant glioma	0.000467	0.0259	CbGpPWpGaD
Hydroxyurea—Haemoglobin—Temozolomide—malignant glioma	0.00046	0.00622	CcSEcCtD
Hydroxyurea—RRM2—central nervous system—malignant glioma	0.000459	0.0707	CbGeAlD
Hydroxyurea—Haemorrhage—Temozolomide—malignant glioma	0.000457	0.00619	CcSEcCtD
Hydroxyurea—Hallucination—Temozolomide—malignant glioma	0.000455	0.00616	CcSEcCtD
Hydroxyurea—CYP2D6—Fatty acids—CYP2B6—malignant glioma	0.000455	0.0252	CbGpPWpGaD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—POR—malignant glioma	0.000426	0.0236	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.000425	0.0235	CbGpPWpGaD
Hydroxyurea—Alopecia—Carmustine—malignant glioma	0.000418	0.00566	CcSEcCtD
Hydroxyurea—Angiopathy—Temozolomide—malignant glioma	0.000415	0.00561	CcSEcCtD
Hydroxyurea—Erythema—Carmustine—malignant glioma	0.000412	0.00557	CcSEcCtD
Hydroxyurea—Chills—Temozolomide—malignant glioma	0.00041	0.00555	CcSEcCtD
Hydroxyurea—Alopecia—Temozolomide—malignant glioma	0.000404	0.00547	CcSEcCtD
Hydroxyurea—Erythema—Temozolomide—malignant glioma	0.000398	0.00539	CcSEcCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—TOP2A—malignant glioma	0.000384	0.0213	CbGpPWpGaD
Hydroxyurea—RRM1—central nervous system—malignant glioma	0.000382	0.0587	CbGeAlD
Hydroxyurea—Anaemia—Carmustine—malignant glioma	0.000381	0.00515	CcSEcCtD
Hydroxyurea—RRM1—cerebellum—malignant glioma	0.000373	0.0574	CbGeAlD
Hydroxyurea—Ill-defined disorder—Temozolomide—malignant glioma	0.000369	0.005	CcSEcCtD
Hydroxyurea—Leukopenia—Carmustine—malignant glioma	0.000369	0.00499	CcSEcCtD
Hydroxyurea—Anaemia—Temozolomide—malignant glioma	0.000368	0.00498	CcSEcCtD
Hydroxyurea—RRM1—Nucleotide metabolism—CAT—malignant glioma	0.000367	0.0203	CbGpPWpGaD
Hydroxyurea—RRM2—brain—malignant glioma	0.000365	0.0561	CbGeAlD
Hydroxyurea—CYP2D6—Xenobiotics—CYP2B6—malignant glioma	0.000361	0.02	CbGpPWpGaD
Hydroxyurea—Malaise—Temozolomide—malignant glioma	0.000359	0.00486	CcSEcCtD
Hydroxyurea—Convulsion—Carmustine—malignant glioma	0.000357	0.00483	CcSEcCtD
Hydroxyurea—Leukopenia—Temozolomide—malignant glioma	0.000356	0.00482	CcSEcCtD
Hydroxyurea—Convulsion—Temozolomide—malignant glioma	0.000345	0.00467	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000337	0.00455	CcSEcCtD
Hydroxyurea—Oedema—Carmustine—malignant glioma	0.000336	0.00455	CcSEcCtD
Hydroxyurea—Discomfort—Temozolomide—malignant glioma	0.000335	0.00453	CcSEcCtD
Hydroxyurea—Infection—Carmustine—malignant glioma	0.000334	0.00452	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Carmustine—malignant glioma	0.000329	0.00445	CcSEcCtD
Hydroxyurea—Oedema—Temozolomide—malignant glioma	0.000325	0.0044	CcSEcCtD
Hydroxyurea—Infection—Temozolomide—malignant glioma	0.000323	0.00437	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000322	0.0178	CbGpPWpGaD
Hydroxyurea—Anorexia—Carmustine—malignant glioma	0.00032	0.00434	CcSEcCtD
Hydroxyurea—Nervous system disorder—Temozolomide—malignant glioma	0.000319	0.00431	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Temozolomide—malignant glioma	0.000318	0.0043	CcSEcCtD
Hydroxyurea—Skin disorder—Temozolomide—malignant glioma	0.000316	0.00427	CcSEcCtD
Hydroxyurea—CYP2D6—Xenobiotics—CYP2C18—malignant glioma	0.000313	0.0174	CbGpPWpGaD
Hydroxyurea—Anorexia—Temozolomide—malignant glioma	0.00031	0.00419	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000305	0.0169	CbGpPWpGaD
Hydroxyurea—RRM1—brain—malignant glioma	0.000303	0.0466	CbGeAlD
Hydroxyurea—RRM2—Nucleotide metabolism—CAT—malignant glioma	0.000302	0.0167	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Carmustine—malignant glioma	0.0003	0.00406	CcSEcCtD
Hydroxyurea—Somnolence—Carmustine—malignant glioma	0.000299	0.00404	CcSEcCtD
Hydroxyurea—Decreased appetite—Carmustine—malignant glioma	0.000292	0.00395	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Carmustine—malignant glioma	0.00029	0.00393	CcSEcCtD
Hydroxyurea—Dyspnoea—Temozolomide—malignant glioma	0.00029	0.00392	CcSEcCtD
Hydroxyurea—Somnolence—Temozolomide—malignant glioma	0.000289	0.00391	CcSEcCtD
Hydroxyurea—Constipation—Carmustine—malignant glioma	0.000287	0.00389	CcSEcCtD
Hydroxyurea—Pain—Carmustine—malignant glioma	0.000287	0.00389	CcSEcCtD
Hydroxyurea—Dyspepsia—Temozolomide—malignant glioma	0.000286	0.00387	CcSEcCtD
Hydroxyurea—Decreased appetite—Temozolomide—malignant glioma	0.000282	0.00382	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00028	0.00379	CcSEcCtD
Hydroxyurea—Fatigue—Temozolomide—malignant glioma	0.00028	0.00379	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—TUBG2—malignant glioma	0.00028	0.0155	CbGpPWpGaD
Hydroxyurea—Constipation—Temozolomide—malignant glioma	0.000278	0.00376	CcSEcCtD
Hydroxyurea—Pain—Temozolomide—malignant glioma	0.000278	0.00376	CcSEcCtD
Hydroxyurea—Feeling abnormal—Carmustine—malignant glioma	0.000277	0.00375	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.000272	0.0151	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—TOP2A—malignant glioma	0.000271	0.015	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Temozolomide—malignant glioma	0.000268	0.00362	CcSEcCtD
Hydroxyurea—Body temperature increased—Carmustine—malignant glioma	0.000266	0.0036	CcSEcCtD
Hydroxyurea—Body temperature increased—Temozolomide—malignant glioma	0.000257	0.00347	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—TUBG2—malignant glioma	0.00025	0.0138	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.000249	0.0138	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Carmustine—malignant glioma	0.000248	0.00335	CcSEcCtD
Hydroxyurea—Asthenia—Carmustine—malignant glioma	0.000241	0.00326	CcSEcCtD
Hydroxyurea—Hypersensitivity—Temozolomide—malignant glioma	0.000239	0.00324	CcSEcCtD
Hydroxyurea—Asthenia—Temozolomide—malignant glioma	0.000233	0.00315	CcSEcCtD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—TP53—malignant glioma	0.000231	0.0128	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Carmustine—malignant glioma	0.00023	0.00311	CcSEcCtD
Hydroxyurea—CYP2D6—brainstem—malignant glioma	0.000225	0.0346	CbGeAlD
Hydroxyurea—Dizziness—Carmustine—malignant glioma	0.000222	0.00301	CcSEcCtD
Hydroxyurea—Diarrhoea—Temozolomide—malignant glioma	0.000222	0.00301	CcSEcCtD
Hydroxyurea—RRM1—E2F transcription factor network—CDKN2A—malignant glioma	0.00022	0.0122	CbGpPWpGaD
Hydroxyurea—Dizziness—Temozolomide—malignant glioma	0.000215	0.00291	CcSEcCtD
Hydroxyurea—Vomiting—Carmustine—malignant glioma	0.000214	0.00289	CcSEcCtD
Hydroxyurea—Rash—Carmustine—malignant glioma	0.000212	0.00287	CcSEcCtD
Hydroxyurea—Dermatitis—Carmustine—malignant glioma	0.000212	0.00287	CcSEcCtD
Hydroxyurea—Headache—Carmustine—malignant glioma	0.000211	0.00285	CcSEcCtD
Hydroxyurea—Vomiting—Temozolomide—malignant glioma	0.000207	0.00279	CcSEcCtD
Hydroxyurea—Rash—Temozolomide—malignant glioma	0.000205	0.00277	CcSEcCtD
Hydroxyurea—Dermatitis—Temozolomide—malignant glioma	0.000205	0.00277	CcSEcCtD
Hydroxyurea—Headache—Temozolomide—malignant glioma	0.000204	0.00275	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—RTEL1—malignant glioma	0.000202	0.0112	CbGpPWpGaD
Hydroxyurea—Nausea—Carmustine—malignant glioma	0.0002	0.0027	CcSEcCtD
Hydroxyurea—CYP2D6—telencephalon—malignant glioma	0.000199	0.0307	CbGeAlD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN2B—malignant glioma	0.000194	0.0107	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000194	0.0107	CbGpPWpGaD
Hydroxyurea—Nausea—Temozolomide—malignant glioma	0.000193	0.00261	CcSEcCtD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—TP53—malignant glioma	0.00019	0.0105	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—MDM2—malignant glioma	0.000186	0.0103	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—RAF1—malignant glioma	0.000185	0.0102	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—CDKN2A—malignant glioma	0.000181	0.01	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.00018	0.00997	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000178	0.00988	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—RTEL1—malignant glioma	0.000167	0.00923	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000162	0.00897	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—MDM2—malignant glioma	0.000153	0.00846	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—RAF1—malignant glioma	0.000152	0.00843	CbGpPWpGaD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00015	0.00831	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—MYC—malignant glioma	0.000149	0.00826	CbGpPWpGaD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000148	0.0082	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000145	0.00802	CbGpPWpGaD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00013	0.00721	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.00013	0.00718	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—MYC—malignant glioma	0.00013	0.00718	CbGpPWpGaD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000128	0.00711	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—PLK1—malignant glioma	0.000128	0.00711	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—HIST1H3B—malignant glioma	0.000127	0.00704	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000126	0.00696	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000124	0.00688	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—MYC—malignant glioma	0.000123	0.0068	CbGpPWpGaD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000122	0.00674	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—COX8A—malignant glioma	0.000116	0.00644	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—PLK1—malignant glioma	0.000115	0.00636	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—HIST1H3B—malignant glioma	0.000114	0.0063	CbGpPWpGaD
Hydroxyurea—CYP2D6—central nervous system—malignant glioma	0.000113	0.0175	CbGeAlD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN2A—malignant glioma	0.000111	0.00614	CbGpPWpGaD
Hydroxyurea—CYP2D6—cerebellum—malignant glioma	0.000111	0.0171	CbGeAlD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—MYC—malignant glioma	0.000107	0.00591	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—TP53—malignant glioma	0.000106	0.0059	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000106	0.00586	CbGpPWpGaD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000105	0.00584	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.0001	0.00556	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—TOP2A—malignant glioma	9.92e-05	0.00549	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	9.89e-05	0.00548	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ASMT—malignant glioma	9.89e-05	0.00547	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	9.86e-05	0.00546	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—H3F3A—malignant glioma	9.82e-05	0.00544	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	9.75e-05	0.0054	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—COX8A—malignant glioma	9.57e-05	0.0053	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	9.54e-05	0.00528	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—YWHAE—malignant glioma	9.46e-05	0.00524	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—BCAN—malignant glioma	9.29e-05	0.00515	CbGpPWpGaD
Hydroxyurea—CYP2D6—brain—malignant glioma	9e-05	0.0139	CbGeAlD
Hydroxyurea—RRM2—G1/S Transition—MYC—malignant glioma	8.92e-05	0.00494	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—TOP2A—malignant glioma	8.87e-05	0.00491	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	8.85e-05	0.0049	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—H3F3A—malignant glioma	8.78e-05	0.00486	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—TP53—malignant glioma	8.77e-05	0.00486	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—YWHAE—malignant glioma	8.46e-05	0.00469	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	8.32e-05	0.00461	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ASMT—malignant glioma	8.14e-05	0.00451	CbGpPWpGaD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	7.99e-05	0.00443	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—BCAN—malignant glioma	7.65e-05	0.00424	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—MYC—malignant glioma	7.51e-05	0.00416	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	7.51e-05	0.00416	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—IDH2—malignant glioma	7.49e-05	0.00415	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN2B—malignant glioma	7.11e-05	0.00394	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP2B6—malignant glioma	7.04e-05	0.0039	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	6.91e-05	0.00383	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	6.76e-05	0.00374	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP2B6—malignant glioma	6.46e-05	0.00358	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—IDH1—malignant glioma	6.44e-05	0.00357	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	6.44e-05	0.00357	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—BRCA2—malignant glioma	6.41e-05	0.00355	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	6.39e-05	0.00354	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP2B6—malignant glioma	6.37e-05	0.00353	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDKN2B—malignant glioma	6.36e-05	0.00352	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—SPHK1—malignant glioma	6.23e-05	0.00345	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—IDH2—malignant glioma	6.17e-05	0.00342	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—BIRC5—malignant glioma	6.14e-05	0.0034	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP2C18—malignant glioma	6.11e-05	0.00338	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	5.87e-05	0.00325	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP2B6—malignant glioma	5.8e-05	0.00321	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	5.68e-05	0.00314	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP2C18—malignant glioma	5.6e-05	0.0031	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP2C18—malignant glioma	5.53e-05	0.00306	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—BIRC5—malignant glioma	5.49e-05	0.00304	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—TERT—malignant glioma	5.31e-05	0.00294	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—IDH1—malignant glioma	5.3e-05	0.00294	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—SPHK1—malignant glioma	5.13e-05	0.00284	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP2C18—malignant glioma	5.03e-05	0.00279	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTT1—malignant glioma	4.94e-05	0.00274	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	4.79e-05	0.00265	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PTGS1—malignant glioma	4.63e-05	0.00256	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTT1—malignant glioma	4.53e-05	0.00251	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—BCHE—malignant glioma	4.3e-05	0.00238	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—SLC5A5—malignant glioma	4.25e-05	0.00235	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—PTGS1—malignant glioma	4.25e-05	0.00235	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTT1—malignant glioma	4.07e-05	0.00225	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN2A—malignant glioma	4.07e-05	0.00225	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PTGS1—malignant glioma	3.81e-05	0.00211	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDKN2A—malignant glioma	3.64e-05	0.00201	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—BCHE—malignant glioma	3.54e-05	0.00196	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—MDM2—malignant glioma	3.53e-05	0.00195	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—SLC5A5—malignant glioma	3.5e-05	0.00194	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTP1—malignant glioma	3.42e-05	0.0019	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CAT—malignant glioma	3.33e-05	0.00185	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—RTEL1—malignant glioma	3.18e-05	0.00176	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—NCOR1—malignant glioma	3.15e-05	0.00174	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTP1—malignant glioma	3.14e-05	0.00174	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	3.1e-05	0.00172	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTP1—malignant glioma	2.82e-05	0.00156	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MYC—malignant glioma	2.76e-05	0.00153	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CAT—malignant glioma	2.74e-05	0.00152	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NCOR1—malignant glioma	2.59e-05	0.00143	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CAV1—malignant glioma	2.56e-05	0.00142	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—MYC—malignant glioma	2.46e-05	0.00136	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PIK3CG—malignant glioma	2.34e-05	0.00129	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PPARG—malignant glioma	2.25e-05	0.00125	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CAV1—malignant glioma	2.11e-05	0.00117	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PIK3CD—malignant glioma	2.05e-05	0.00114	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—TP53—malignant glioma	2.02e-05	0.00112	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CG—malignant glioma	1.92e-05	0.00107	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PPARG—malignant glioma	1.86e-05	0.00103	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—COX8A—malignant glioma	1.82e-05	0.00101	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PIK3CB—malignant glioma	1.79e-05	0.000991	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PTGS2—malignant glioma	1.77e-05	0.000982	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CD—malignant glioma	1.69e-05	0.000937	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ASMT—malignant glioma	1.55e-05	0.000859	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PTEN—malignant glioma	1.55e-05	0.000857	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CB—malignant glioma	1.47e-05	0.000816	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PTGS2—malignant glioma	1.46e-05	0.000809	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—BCAN—malignant glioma	1.46e-05	0.000808	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PTEN—malignant glioma	1.27e-05	0.000705	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—IDH2—malignant glioma	1.18e-05	0.000651	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP2B6—malignant glioma	1.11e-05	0.000612	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PIK3CA—malignant glioma	1.09e-05	0.000604	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—IDH1—malignant glioma	1.01e-05	0.00056	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SPHK1—malignant glioma	9.78e-06	0.000542	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP2C18—malignant glioma	9.58e-06	0.000531	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CA—malignant glioma	8.99e-06	0.000498	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—AKT1—malignant glioma	8.91e-06	0.000494	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTT1—malignant glioma	7.75e-06	0.000429	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—AKT1—malignant glioma	7.34e-06	0.000407	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PTGS1—malignant glioma	7.26e-06	0.000402	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—BCHE—malignant glioma	6.75e-06	0.000374	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SLC5A5—malignant glioma	6.67e-06	0.000369	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTP1—malignant glioma	5.37e-06	0.000297	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CAT—malignant glioma	5.23e-06	0.000289	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NCOR1—malignant glioma	4.94e-06	0.000273	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CAV1—malignant glioma	4.02e-06	0.000223	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CG—malignant glioma	3.67e-06	0.000203	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PPARG—malignant glioma	3.54e-06	0.000196	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CD—malignant glioma	3.22e-06	0.000178	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.81e-06	0.000156	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PTGS2—malignant glioma	2.78e-06	0.000154	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PTEN—malignant glioma	2.43e-06	0.000134	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.71e-06	9.48e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—AKT1—malignant glioma	1.4e-06	7.75e-05	CbGpPWpGaD
